ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (TAK US)

11
Analysis
Health Care • Japan
Takeda Pharmaceutical Company Limited is engaged in research and development, manufacturing, sales and marketing, and import and export of pharmaceutical drugs. The Company focuses on the core therapeutic areas of oncology, gastrointestinal, and central nervous system disease.
more
•05 Jun 2024 20:57

#8 India Insight: Novelis IPO Postponed, TMFL Merger, Angle One Client Growth, NSE World Record

​Hindalco Industries postpones Novelis Corporation IPO, Tata Motors Finance to merge with Tata Capital, NSE sets world record for transactions in a...

Logo
435 Views
Share
bullish•Silver
•22 Apr 2024 05:32

Silver Measured Move to 35.50

Gold looks a bit fatigued and silver likely to play catch up. Greenback could present headwinds for equities. Japan reverses big gains in 2024.

Logo
460 Views
Share
bullish•Takeda Pharmaceutical
•25 Aug 2020 13:36

Takeda Sells Japan OTC Business to Blackstone; Last of Its Non-Core Asset Sales to Raise US$10bn

Takeda announced on Monday (24th August 2020) that it has entered into an agreement to sell its domestic consumer health business (known as Takeda...

Share
bullish•Quantitative Analysis
•16 Jun 2020 23:10

TOPIX Inclusion (9273 JP): Koa Shoji Holdings

Koa Shoji Holdings (9273 JP)  confirmed (J-only) on 15th June they had received approval to move from the Second Section to the First Section of...

Share
bullish•Takeda Pharmaceutical
•29 Apr 2020 14:02

Takeda Pharma Divests Yet Another Non-Core Asset to Pay-Off Debt and Focus on Core Areas

On 24th April, Takeda Pharmaceutical announced that it has entered into an agreement to sell off a portfolio of select non-core over the counter...

Share
x